Delivery Order SPE2DB22D1041-SPE2DB25FTYP4
Award Date
11/27/24
Potential Completion Date
11/29/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,992.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a prescription medication. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of November 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,904.95 firm fixed-price contract is for Advair HFA 115-21 MCG Inhaler 12GM, a respiratory medication. The contract has an ultimate completion date of January 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $2,301.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of June 25, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,270.22, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a critical pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.46, is a delivery order for the supply of an Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of January 28, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $4,964.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 mcg Inhaler 12gm, a pharmaceutical product. The contract has a firm fixed price structure and an ultimate completion date of March 27, 2025. While the original solicitation is not provided, the award indicates that Amerisourcebergen holds a...
This federal contract award is a delivery order worth $2,056.62 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of Advair HFA 230-21 MCG Inhaler, a prescription medication, with a completion date of December 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,055.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication, with an ultimate completion date of August 23, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
This federal contract award, valued at $2,325.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a completion date of January 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen is the prime contractor and holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,493.95 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of March 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...